Clinical research associate selected to present at national oncology meeting

July 8, 2020

Shirley Cheng, University of Hawaiʻi Cancer Center clinical research associate, was one of three candidates selected to present their abstract at the 12th Annual Association of American Cancer Institutes Clinical Research Innovations Meeting. Of the 77 abstracts submitted, Cheng’s won second place. Each abstract focused on solutions tested and implemented to address clinical research challenges that can impede cancer drug development.

Shirley Cheng seen here (bottom frame) presenting her abstract at the virtual meeting

Cheng presented her abstract at the virtual meeting on July 8, 2020. Following her presentation, she responded to questions from the audience of over 800 attendees during a panel discussion. Her study examines the challenges and successes of enrolling participants onto the Tomosynthesis Mammographic Imaging Screening Trial (TMIST) in Hawaiʻi’s Minority/Underserved National Cancer Institute Community Oncology Research Program.

Hawaiʻi is the most diverse state in the nation, and the enrollment of ethnic minorities onto the TMIST study ensures results are universally applicable. The study aims to increase the number of participants enrolling onto the study, with a focus on Native Hawaiians and Pacific Islanders, supply resources to those who are uninsured and provide education about clinical trials.

View the 2020 Abstracts